Point72 Asset Management
KRSA

Point72 Asset Management’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Point72 Asset Management’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-994
Closed -$379K – 831
2019
Q4 		$379K Buy
+994
New +$92.8K ﹤0.01% 797

Other funds holding KRSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Point72 Asset Management's KRSA Position: Q1 2020 in Review

Point72 Asset Management sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q1 2020, closing a stake of 994 shares — an estimated $379K sold.

Point72 Asset Management first reported a position in KRSA in Q4 2019 and held it in 1 quarter. The position peaked at $379K in Q4 2019. 74 funds tracked by Wall St. Rank hold KRSA as of Q1 2020.

  • Point72 Asset Management reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Point72 Asset Management sold 994 Korsana Biosciences, Inc. Common Stock shares in Q1 2020, an estimated $379K.
  • Point72 Asset Management first reported a position in Korsana Biosciences, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Point72 Asset Management's Korsana Biosciences, Inc. Common Stock position peaked at $379K in Q4 2019.
  • 74 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q1 2020.

Based on Point72 Asset Management's 13F filing for Q1 2020, filed 15 May 2020.